首页 | 本学科首页   官方微博 | 高级检索  
     

清瘟败毒饮治疗流行性出血热120例临床观察
引用本文:郝向春,马素娟,陈玉良. 清瘟败毒饮治疗流行性出血热120例临床观察[J]. 中国中西医结合急救杂志, 2001, 8(1): 45-46
作者姓名:郝向春  马素娟  陈玉良
作者单位:河北省抚宁县中医院,
基金项目:河北省秦皇岛市科研基金资助项目(No.199916)
摘    要:目的:观察清瘟败毒饮治疗流行性出血热的临床疗效。方法:将发病5日内入院的流行性出血热患者180例随机分成2组。对照组60例邓病毒唑静滴,同时予液体疗法,对症处理并发症。治疗组120例在对照组治疗基础上根据不同病期配合清瘟败毒饮Ⅰ、Ⅱ、Ⅲ号口服,每日2次。结果:治疗组平均发热天数、多尿天数、血小板恢复正常天数、尿蛋白转阴天数明显短于对照组(P均<0.01),其少尿期越期率、低血压休克期越期率亦明显高于对照组(P均<0.01)并发症发生率低于对照组(P<0.05)。结论:加用清瘟败毒饮治疗流行性出血热疗效显著,无不良反应。

关 键 词:清温败毒饮 流行性出血热 病毒唑 治疗
文章编号:1008-9691(2001)01-0045-02
修稿时间:2000-03-29

Clinical observations ontreatment with Qingwen Baidu drink(
HAO Xiangchun,Ma Sujuan,Chen Yuliang. Clinical observations ontreatment with Qingwen Baidu drink([J]. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, 2001, 8(1): 45-46
Authors:HAO Xiangchun  Ma Sujuan  Chen Yuliang
Abstract:Objective:To observe the clinically curative effects of Qingwen Baidu drink(清瘟败毒饮) on epidemic hemorrhagic fever (EHF).Methods:One hundred and eighty cases with EHF who were admitted to hospital within 5 days after onset were randomly divided into two groups.The control group (n=60) was treated with Ribavirin infused intravenously and liquid therapy,and treating complications simultaneously,meanwhile the treated group (n=120) based on the same therapy as control group treated with Qingwen Baidu drink number Ⅰ,Ⅱ or Ⅲtaken orally two times a day according to different course.Results:In treated group all the days of fever,polyuria,recovering platelet to normal,and transforming proteinuria to negative were significantly shorter than those in control group (both P<0.01),otherwise the overphase rates of oliguria and hypotension shock were higher than those in control group too (all P<0.01).The occurance rate of complications in treated group was lower than that in control group(P<0.05).Conclusions:The curative effects adding Qingwen Baidu drink on EHF are significant and worth spreading.
Keywords:
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号